Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 3 11Phase 1/2 7Phase 1 7Phase 2/3 2Phase 4 1

Status

Completed 37Terminated 20Recruiting 16Active not recruiting 7Unknown 5Withdrawn 4Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 4Stomach Neoplasms 1Solid Cancer 1Neoplasm Metastasis 1Gliosarcoma 1Glioblastoma 1Anal Cancer Metastatic 1

Interventions

pembrolizumab 70Nivolumab 36Cyclophosphamide 34Carboplatin 28Dexamethasone 23Specimen Handling 22Paclitaxel 22Lenalidomide 22durvalumab 19Radiotherapy 19Gemcitabine 19venetoclax 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Rituximab 16fludarabine 15Ipilimumab 15Bevacizumab 15Cisplatin 14Biopsy 14atezolizumab 13Etoposide 13Vincristine 12Pemetrexed 12belantamab mafodotin 11Docetaxel 11Calcium Dobesilate 11Azacitidine 11olaparib 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × Albumin-Bound Paclitaxel × Clear all
NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting
122 enrolled
Gastrointestinal

Anal Cancer Metastatic

NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting
57 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT06771622 2026-02-04

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

FBD Biologics Limited

Phase 1/2 Active not recruiting
500 enrolled

Solid Cancer

NCT04396821 2025-12-17

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

Suzhou Transcenta Therapeutics Co., Ltd.

Phase 1/2 Active not recruiting
150 enrolled
Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms

NCT02481635 2025-12-08

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

University Health Network, Toronto

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04821284 2025-11-04

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

Thomas Jefferson University

Phase 1/2 Active not recruiting
120 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05669482 2025-09-02

RAMP205

Verastem, Inc.

Phase 1/2 Active not recruiting
40 enrolled
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡